Raleigh Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-204
| Closed | -$15.9K | – | 699 |
|
|
2024
Q4 | $15.9K | Buy |
204
+85
| +71% | +$6.61K | 0.01% | 509 |
|
|
2024
Q3 | $7.98K | Sell |
119
-33
| -22% | -$2.21K | ﹤0.01% | 634 |
|
|
2024
Q2 | $17.2K | Buy |
152
+1
| +0.7% | +$113 | 0.01% | 450 |
|
|
2024
Q1 | $20.9K | Buy |
151
+97
| +180% | +$13.5K | 0.01% | 417 |
|
|
2023
Q4 | $6.72K | Buy |
54
+50
| +1,250% | +$6.22K | ﹤0.01% | 679 |
|
|
2023
Q3 | $384 | Buy |
+4
| New | +$384 | ﹤0.01% | 897 |
|
|
2023
Q2 | – | Sell |
-23
| Closed | -$2.67K | – | 861 |
|
|
2023
Q1 | $2.67K | Buy |
+23
| New | +$2.67K | ﹤0.01% | 736 |
|